ECA has been found to inhibit the HIF pathway by downregulating the mRNA expression of VEGF, a downstream target gene of HIF-1a, in HeLa cells under hypoxia, thereby inhibiting tumor angiogenesis and metastasis [83]. Here, HIF1A is linked to neoplasm.